Loading...
Date of Award
Spring 2025
Degree Name
Master of Medical Science (Physician Assistant)
Department
Physician Assistant; College of Health Sciences
First Advisor
Timothy Besse
Abstract
Cardiac amyloidosis (CA) is thought of as a rare cause of heart failure, although underdiagnosis makes its true prevalence difficult to discern. Advances in diagnosis have revealed that CA is likely more prevalent than once previously believed. Despite the advances in treatment for cardiac amyloidosis, prognosis remains poor. Early recognition of “red flags” reduces delays in diagnosis and treatment. Additionally, as incidence of CA increases, clinicians must understand the treatment of CA and how it differs from other forms of heart failure. This CME emphasizes different epidemiological features and “red flags” that may alert a clinician to screen for cardiac amyloidosis. It will then discuss the diagnostic workup and treatment for CA and its comorbidities.
Recommended Citation
Marks, Christine, "Cardiac Amyloidosis: An Underdiagnosed Cause of Heart Failure" (2025). Capstone Showcase. 4.
https://scholarworks.arcadia.edu/showcase/2025/pa/4
Cardiac Amyloidosis: An Underdiagnosed Cause of Heart Failure
Cardiac amyloidosis (CA) is thought of as a rare cause of heart failure, although underdiagnosis makes its true prevalence difficult to discern. Advances in diagnosis have revealed that CA is likely more prevalent than once previously believed. Despite the advances in treatment for cardiac amyloidosis, prognosis remains poor. Early recognition of “red flags” reduces delays in diagnosis and treatment. Additionally, as incidence of CA increases, clinicians must understand the treatment of CA and how it differs from other forms of heart failure. This CME emphasizes different epidemiological features and “red flags” that may alert a clinician to screen for cardiac amyloidosis. It will then discuss the diagnostic workup and treatment for CA and its comorbidities.